Clinical Trials
4
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
A Pooled Analysis of Long-Term Outcomes After Inhaled Isoflurane Via the Sedaconda ACD-S Compared to Intravenous Propofol
- Conditions
- Post-Intensive Care SyndromeSedation
- Interventions
- Drug: Inhaled isoflurane administered by Sedaconda ACD-SDrug: Intravenous infusion of propofol
- First Posted Date
- 2025-02-05
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- Sedana Medical
- Target Recruit Count
- 312
- Registration Number
- NCT06809218
- Locations
- 🇺🇸
The Critical Illness, Brain Dysfunction and Survivorship (CIBS) Center, Nashville, Tennessee, United States
Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU2)
- First Posted Date
- 2022-04-14
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- Sedana Medical
- Target Recruit Count
- 235
- Registration Number
- NCT05327296
- Locations
- 🇺🇸
Memorial Health Services, Long Beach, California, United States
🇺🇸University of California, Los Angeles, Los Angeles, California, United States
🇺🇸Stanford University, Redwood City, California, United States
Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU1)
- First Posted Date
- 2022-04-05
- Last Posted Date
- 2024-05-03
- Lead Sponsor
- Sedana Medical
- Target Recruit Count
- 235
- Registration Number
- NCT05312385
- Locations
- 🇺🇸
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
🇺🇸Emory University, Atlanta, Georgia, United States
🇺🇸University of Chicago, Chicago, Illinois, United States
Effect & Safety of Inhaled Isoflurane vs IV Midazolam for Sedation in Mechanically Ventilated Children 3-17 Years Old
- First Posted Date
- 2020-12-24
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- Sedana Medical
- Target Recruit Count
- 94
- Registration Number
- NCT04684238
- Locations
- 🇫🇷
Hôpital Femme-Mère-Enfant Groupe Hospitalier Est, Lyon, France
🇫🇷CHU de NANTES, Hôpital Mère-Enfant, Nantes, France
🇫🇷Hôpital Robert-Debré AP-HP, Paris, France